Mapping the central effects of ketamine in the rat using pharmacological MRI

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Psychopharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00213-006-0544-7PMID 16550385
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacological applications of magnetic resonance imaging.

  2025cited by this paper
• Mapping the central effects of ketamine in the rat using pharmacological MRI

  2006cited by this paper
• Mapping dopamine D2/D3 receptor function using pharmacological magnetic resonance imaging

  2005cited by this paper
• Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics

  2005cited by this paper
• Examining the neural targets of the AMPA receptor potentiator LY404187 in the rat brain using pharmacological magnetic resonance imaging

  2005cited by this paper
• Effects of hypoxia, hyperoxia, and hypercapnia on baseline and stimulus-evoked BOLD, CBF, and CMRO2 in spontaneously breathing animals

  2005cited by this paper
• Behavioural and pharmacological magnetic resonance imaging assessment of the effects of methylphenidate in a potential new rat model of attention deficit hyperactivity disorder

  2005cited by this paper
• Ketamine Induces Dopamine-Dependent Depression of Evoked Hippocampal Activity in the Nucleus Accumbens in Freely Moving Rats

  2005cited by this paper
• Mapping interactions between dopamine and adenosine A2a receptors using pharmacologic MRI

  2005cited by this paper
• Mapping the effects of the selective dopamine D2/D3 receptor agonist quinelorane using pharmacological magnetic resonance imaging.

  2005cited by this paper
• Dopamine antagonist modulation of amphetamine response as detected using pharmacological MRI.

  2005cited by this paper
• Concurrent pharmacological MRI and in situ microdialysis of cocaine reveal a complex relationship between the central hemodynamic response and local dopamine concentration

  2004cited by this paper
• Repeated application of ketamine to rats induces changes in the hippocampal expression of parvalbumin, neuronal nitric oxide synthase and cFOS similar to those found in human schizophrenia.

  2004cited by this paper
• Effects of Subanesthetic Ketamine on Regional Cerebral Glucose Metabolism in Humans

  2004cited by this paper
• Imaging oxygen consumption in forepaw somatosensory stimulation in rats under isoflurane anesthesia

  2004cited by this paper
• Acute Effects of Ketamine on Memory Systems and Psychotic Symptoms in Healthy Volunteers

  2004cited by this paper
• Negative BOLD in the visual cortex: Evidence against blood stealing

  2004cited by this paper
• Effects of Ketamine on Isoflurane- and Sevoflurane-Induced Cerebral Vasodilation in Rabbits

  2003cited by this paper
• Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268.

  2003cited by this paper
• Regional Cerebral Blood Flow and BOLD Responses in Conscious and Anesthetized Rats under Basal and Hypercapnic Conditions: Implications for Functional MRI Studies

  2003cited by this paper
• Effects of Subanesthetic Doses of Ketamine on Regional Cerebral Blood Flow, Oxygen Consumption, and Blood Volume in Humans

  2003cited by this paper
• Origin of Negative Blood Oxygenation Level—Dependent fMRI Signals

  2002cited by this paper
• Ketamine-induced c-Fos expression in the mouse posterior cingulate and retrosplenial cortices is mediated not only via NMDA receptors but also via sigma receptors.

  2002cited by this paper
• NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D2 and serotonin 5-HT2 receptors—implications for models of schizophrenia

  2002cited by this paper
• Noise Reduction in BOLD-Based fMRI Using Component Analysis

  2002cited by this paper
• Fast robust automated brain extraction

  2002cited by this paper
• Blood Pressure Changes Induced by Arterial Blood Withdrawal Influence Bold Signal in Anesthesized Rats at 7 Tesla: Implications for Pharmacologic MRI

  2001cited by this paper
• Effects of Ketamine in Normal and Schizophrenic Volunteers

  2001cited by this paper
• A neurobiological basis for substance abuse comorbidity in schizophrenia.

  2001cited by this paper
• The Effects of Topical and Intravenous Ketamine on Cerebral Arterioles in Dogs Receiving Pentobarbital or Isoflurane Anesthesia

  2001cited by this paper
• Mapping of brain activation in response to pharmacological agents using fMRI in the rat.

  2001cited by this paper
• Detection of pharmacologically mediated changes in cerebral activity by functional magnetic resonance imaging: the effects of sulpiride in the brain of the anaesthetised rat.

  2001cited by this paper
• Psychosis: pathological activation of limbic thalamocortical circuits by psychomimetics and schizophrenia?

  2001cited by this paper
• LY393558, a 5-hydroxytryptamine reuptake inhibitor and 5-HT(1B/1D) receptor antagonist: effects on extracellular levels of 5-hydroxytryptamine in the guinea pig and rat.

  2001cited by this paper
• NMDA receptor antagonist-induced dopamine release in the ventral pallidum does not correlate with motor activation.

  2000cited by this paper
• Evidence for GABAA Receptor Agonistic Properties of Ketamine: Convulsive and Anesthetic Behavioral Models in Mice

  2000cited by this paper
• Dysfunctional brain dopamine systems induced by psychotomimetic NMDA-receptor antagonists and the effects of antipsychotic drugs.

  2000cited by this paper
• Gating of information flow within the limbic system and the pathophysiology of schizophrenia.

  2000cited by this paper
• Pharmacological magnetic resonance imaging: a new application for functional MRI.

  2000cited by this paper
• Contrasting Synaptic Actions of the Inhalational General Anesthetics Isoflurane and Xenon

  2000cited by this paper
• The effects of propofol with and without ketamine on human cerebral blood flow velocity and CO(2) response.

  2000cited by this paper
• The effect of ketamine isomers on both mice behavioral responses and c-Fos expression in the posterior cingulate and retrosplenial cortices.

  2000cited by this paper
• Comparison of brain metabolic activity patterns induced by ketamine, MK-801 and amphetamine in rats: support for NMDA receptor involvement in responses to subanesthetic dose of ketamine.

  1999cited by this paper
• Ketamine-Induced NMDA Receptor Hypofunction as a Model of Memory Impairment and Psychosis

  1999cited by this paper
• Stereoselective interaction of ketamine with recombinant mu, kappa, and delta opioid receptors expressed in Chinese hamster ovary cells.

  1999cited by this paper
• Dopaminergic regulation of cerebral cortical microcirculation

  1998cited by this paper
• Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin

  1998cited by this paper
• Suppression of vascular artifacts in functional magnetic resonance images using MR angiograms.

  1998cited by this paper
• Metabolic mapping of the rat brain after subanesthetic doses of ketamine: potential relevance to schizophrenia.

  1998cited by this paper
• Corticolimbic Dopamine Neurotransmission Is Temporally Dissociated from the Cognitive and Locomotor Effects of Phencyclidine

  1998cited by this paper
• Clozapine blunts N-methyl-D-aspartate antagonist-induced psychosis: a study with ketamine.

  1997cited by this paper
• Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex

  1997cited by this paper
• Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers.

  1997cited by this paper
• Ketamine Decreases Intracranial Pressure and Electroencephalographic Activity in Traumatic Brain Injury Patients during Propofol Sedation

  1997cited by this paper
• Effects of ketamine on dopamine metabolism during anesthesia in discrete brain regions in mice: comparison with the effects during the recovery and subanesthetic phases.

  1997cited by this paper
• Volatile Anesthetics Depress Glutamate Transmission Via Presynaptic Actions

  1996cited by this paper
• Halothane and Diazepam Inhibit Ketamine‐induced c‐fos Expression in the Rat Cingulate Cortex

  1996cited by this paper
• The N-methyl-d-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias

  1995cited by this paper
• Ketamine Does Not Increase Cerebral Blood Flow Velocity or Intracranial Pressure During Isoflurane/Nitrous Oxide Anesthesia in Patients Undergoing Craniotomy

  1995cited by this paper
• Analysis of fMRI time-series revisited--again.

  1995cited by this paper
• Interaction of the chiral forms of ketamine with opioid, phencyclidine, sigma and muscarinic receptors.

  1995cited by this paper
• Ketamine activates psychosis and alters limbic blood flow in schizophrenia

  1995cited by this paper
• Visualisation of changes in regional cerebral blood flow (rCBF) produced by ketamine using long TE gradient-echo sequences: preliminary results.

  1995cited by this paper
• Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.

  1994cited by this paper
• Cerebral pharmacodynamics of anaesthetic and subanaesthetic doses of ketamine in the normoventilated pig

  1993cited by this paper
• Ketamine inhibition of cytoplasmic calcium signalling in rat pheochromocytoma (PC-12) cells.

  1993cited by this paper
• The glycine/NMDA receptor antagonist, R‐(+)‐HA‐966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK‐801) in rodents

  1993cited by this paper
• The effect of isoflurane on excitatory synaptic transmission in the rat hippocampus

  1992cited by this paper
• Intrinsic signal changes accompanying sensory stimulation: functional brain mapping with magnetic resonance imaging.

  1992cited by this paper
• Time course EPI of human brain function during task activation

  1992cited by this paper
• Ketamine-induced hyperlocomotion associated with alteration of presynaptic components of dopamine neurons in the nucleus accumbens of mice.

  1991cited by this paper
• NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus.

  1990cited by this paper
• Noncompetitive excitatory amino acid receptor antagonists.

  1990cited by this paper
• Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats.

  1989cited by this paper
• Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs.

  1989cited by this paper
• Effect of volatile anesthetics on synaptic transmission in the rat hippocampus.

  1989cited by this paper
• Use-dependent block of excitatory amino acid currents in cultured neurons by ketamine.

  1987cited by this paper
• Ketamine Effects on Local Cerebral Blood Flow and Metabolism in the Rat

  1987cited by this paper
• Ketamine-induced locomotion in rats in an open-field.

  1985cited by this paper
• The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N‐methyl‐aspartate

  1983cited by this paper
• Local Changes in Cerebral Glucose Utilization during Ketamine Anesthesia

  1982cited by this paper
• Effects of Ketamine on Canine Cerebral Blood Flow and Metabolism: Modification by Prior Administration of Thiopental

  1971cited by this paper

• Pharmacological MRI: Utility in Understanding Drug Mechanisms in Psychiatric Disorders

  2025cites this paper
• Psychedelic Therapy: A Primer for Primary Care Clinicians—Ketamine

  2024cites this paper
• Psilocybin reduces alcohol self-administration via selective left nucleus accumbens activation in rats.

  2024cites this paper
• The Evolving Role of Animal Models in the Discovery and Development of Novel Treatments for Psychiatric Disorders.

  2023cites this paper
• Dual action of ketamine confines addiction liability

  2022cites this paper
• Dose‐dependent effects of esketamine on brain activity in awake mice: A BOLD phMRI study

  2022cites this paper
• Revisiting the cerebral hemodynamics of awake, freely moving rats with repeated ketamine self-administration using a miniature photoacoustic imaging system

  2022cites this paper
• Dextromethorphan Reduces Sign-Tracking but Not Goal-Tracking in Male Sprague-Dawley Rats.

  2022cites this paper
• Resting-state connectivity studies as a marker of the acute and delayed effects of subanaesthetic ketamine administration in healthy and depressed individuals: A systematic review

  2021cites this paper
• Systematic Review: Anesthetic Protocols and Management as Confounders in Rodent Blood Oxygen Level Dependent Functional Magnetic Resonance Imaging (BOLD fMRI)—Part B: Effects of Anesthetic Agents, Doses and Timing

  2021cites this paper
• Combined Low Dose of Ketamine and Social Isolation: A Possible Model of Induced Chronic Schizophrenia-Like Symptoms in Male Albino Rats

  2021cites this paper
• Sustained escitalopram administration affects glucose metabolism in the rat brain.

  2021cites this paper
• Neuroprotective effect of agomelatine in rat model of psychosis: Behavioural and histological evidence

  2021cites this paper
• The neurophysiology of ketamine: an integrative review

  2020cites this paper
• Proof of mechanism and target engagement of glutamatergic drugs for the treatment of schizophrenia: RCTs of pomaglumetad and TS-134 on ketamine-induced psychotic symptoms and pharmacoBOLD in healthy volunteers

  2020cites this paper
• Fast-acting antidepressant activity of ketamine: highlights on brain serotonin, glutamate, and GABA neurotransmission in preclinical studies.

  2019cites this paper
• Mapping stress networks using functional magnetic resonance imaging in awake animals

  2018cites this paper
• Mapping the central effects of (±)-ketamine and traxoprodil using pharmacological magnetic resonance imaging in awake rats

  2018cites this paper
• Dose‐response effect of acute phencyclidine on functional connectivity and dopamine levels, and their association with schizophrenia‐like symptom classes in rat

  2017cites this paper
• Ketamine and pharmacological imaging: use of functional magnetic resonance imaging to evaluate mechanisms of action

  2017cites this paper
• Subanesthetic ketamine decreases the incentive-motivational value of reward-related cues

  2017cites this paper
• The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders

  2017cites this paper
• TAK-063, a phosphodiesterase 10A inhibitor, modulates neuronal activity in various brain regions in phMRI and EEG studies with and without ketamine challenge.

  2016cites this paper
• Relating Translational Neuroimaging and Amperometric Endpoints: Utility for Neuropsychiatric Drug Discovery.

  2016cites this paper
• Ketamine abuse potential and use disorder.

  2016cites this paper
• Transiently increased glutamate cycling in rat PFC is associated with rapid onset of antidepressant-like effects

  2016cites this paper
• N-methyl-D-aspartate receptor encephalitis mediates loss of intrinsic activity measured by functional MRI

  2016cites this paper
• Proteomic systems evaluation of the molecular validity of preclinical psychosis models compared to schizophrenia brain pathology.

  2016cites this paper
• Effect of ketamine administration, alone and in combination with E-6837, on climbing behavior

  2016cites this paper
• Neonatal Prefrontal Inactivation Results in Reversed Dopaminergic Responses in the Shell Subregion of the Nucleus Accumbens to NMDA Antagonists.

  2016cites this paper
• A targeted multiplexed proteomic investigation identifies ketamine-induced changes in immune markers in rat serum and expression changes in protein kinases/phosphatases in rat brain.

  2015cites this paper
• Examination of clozapine and haloperidol in improving ketamine-induced deficits in an incremental repeated acquisition procedure in BALB/c mice

  2015cites this paper
• Perceptual distortions and delusional thinking following ketamine administration are related to increased pharmacological MRI signal changes in the parietal lobe

  2015influential citation
• distortions and thinking following ketamine administration are related to increased pharmacological MRI signal changes in the parietal lobe

  2015influential citation
• Role of adult hippocampal neurogenesis in cognition in physiology and disease: pharmacological targets and biomarkers.

  2015cites this paper
• Ketamine and suicidal ideation in depression: Jumping the gun?

  2015cites this paper
• Dissociable Effects of Antipsychotics on Ketamine-Induced Changes in Regional Oxygenation and Inter-Regional Coherence of Low Frequency Oxygen Fluctuations in the Rat

  2014cites this paper
• Sub-Anesthetic Ketamine Modulates Intrinsic BOLD Connectivity Within the Hippocampal-Prefrontal Circuit in the Rat

  2014cites this paper
• In vivo neurometabolic profiling to characterize the effects of social isolation and ketamine-induced NMDA antagonism: a rodent study at 7.0 T.

  2014cites this paper
• Differential effects of NMDA receptor antagonists at lower and higher doses on basal gamma band oscillation power in rat cortical electroencephalograms.

  2014cites this paper
• The contribution of the brain response to ketamine to understanding the glutamatergic system and its role in human cognition

  2013cites this paper
• Subchronic memantine induced concurrent functional disconnectivity and altered ultra-structural tissue integrity in the rodent brain: revealed by multimodal MRI

  2013cites this paper
• Test-retest reliability of the BOLD pharmacological MRI response to ketamine in healthy volunteers

  2013cites this paper
• Parallel Buprenorphine phMRI Responses in Conscious Rodents and Healthy Human Subjects

  2013cites this paper
• Ketamine increases striatal dopamine release and hyperlocomotion in adult rats after postnatal functional blockade of the prefrontal cortex.

  2013cites this paper
• Neural Correlates of Rapid Antidepressant Response to Ketamine in Treatment-Resistant Unipolar Depression: A preliminary PET study

  2013cites this paper
• A schizophrenia rat model induced by early postnatal phencyclidine treatment and characterized by Magnetic Resonance Imaging.

  2013cites this paper
• Ethanol-induced alterations of amino acids measured by in vivo microdialysis in rats: a meta-analysis

  2013influential citation
• Neural correlates of rapid antidepressant response to ketamine in treatment-resistant unipolar depression: a preliminary positron emission tomography study.

  2013cites this paper
• Ketamine disrupts theta synchrony across the septotemporal axis of the CA1 region of hippocampus.

  2013cites this paper
• The NMDA receptor may participate in widespread suppression of circuit level neural activity, in addition to a similarly prominent role in circuit level activation.

  2012cites this paper
• Differential Effects of Anaesthesia on the phMRI Response to Acute Ketamine Challenge.

  2012cites this paper
• NMDA receptors, cognition and schizophrenia--testing the validity of the NMDA receptor hypofunction hypothesis.

  2012cites this paper
• ¹H-[¹³C]-nuclear magnetic resonance spectroscopy measures of ketamine's effect on amino acid neurotransmitter metabolism.

  2012cites this paper
• The glutamate hypothesis of schizophrenia: neuroimaging and drug development.

  2012cites this paper
• Xanomeline Modulation of the Blood Oxygenation Level-Dependent Signal in Awake Rats: Development of Pharmacological Magnetic Resonance Imaging as a Translatable Pharmacodynamic Biomarker for Central Activity and Dose Selection

  2012cites this paper
• Convergence of human brain mapping tools: Neuronavigated TMS Parameters and fMRI activity in the hand motor area

  2012cites this paper
• Pharmacologic magnetic resonance imaging (phMRI): Imaging drug action in the brain

  2012cites this paper
• Electroencephalographic Spectral and Coherence Analysis of Ketamine in Rats: Correlation with Behavioral Effects and Pharmacokinetics

  2011cites this paper
• Structural abnormalities revealed by magnetic resonance imaging in rats prenatally exposed to methylazoxymethanol acetate parallel cerebral pathology in schizophrenia

  2011cites this paper
• Distinct temporal patterns of electrical stimulation influence neural recruitment during PTZ infusion: an fMRI study.

  2011cites this paper
• The in vivo neurochemistry of the brain during general anesthesia

  2011cites this paper
• DISSECTING THE REGISTRATION AND PROCESSING OF OLFACTORY EVENTS DURING GENERAL ANESTHESIA

  2011cites this paper
• Awake Rat Pharmacological Magnetic Resonance Imaging as a Translational Pharmacodynamic Biomarker: Metabotropic Glutamate 2/3 Agonist Modulation of Ketamine-Induced Blood Oxygenation Level Dependence Signals

  2011influential citation
• Role of the Transcription Factor CREB in the NMDA Receptor Antagonist-Induced Attention Deficits

  2011cites this paper
• Neuroadaptive responses to citalopram in rats using pharmacological magnetic resonance imaging

  2011cites this paper
• Na+,K+-ATPase activity is increased in rats subjected to chronic administration of ketamine

  2011cites this paper
• Behavioral changes and mitochondrial dysfunction in a rat model of schizophrenia induced by ketamine

  2011cites this paper
• A Rodent Model of Schizophrenia Reveals Increase in Creatine Kinase Activity with Associated Behavior Changes

  2010cites this paper
• Robust, unbiased general linear model estimation of phMRI signal amplitude in the presence of variation in the temporal response profile

  2010cites this paper
• Antagonism at serotonin 5-HT2A receptors modulates functional activity of frontohippocampal circuit

  2010cites this paper
• Serotonergic lesions of the dorsal hippocampus differentially modulate locomotor hyperactivity induced by drugs of abuse in rats: implications for schizophrenia

  2009cites this paper
• Detection of Visual Activation in the Rat Brain Using 2-deoxy-2-[18F]fluoro-d-glucose and Statistical Parametric Mapping (SPM)

  2009cites this paper
• Glutaminase-Deficient Mice Display Hippocampal Hypoactivity, Insensitivity to Pro-Psychotic Drugs and Potentiated Latent Inhibition: Relevance to Schizophrenia

  2009cites this paper
• Drug-anaesthetic interaction in phMRI: the case of the psychotomimetic agent phencyclidine.

  2008cites this paper
• A pharmacological MRI assessment of dizocilpine (MK-801) in the 3-nitroproprionic acid-lesioned rat.

  2008cites this paper
• Differential Effects of Antipsychotic and Glutamatergic Agents on the phMRI Response to Phencyclidine

  2008cites this paper
• BOLD fMRI mapping of brain responses to nociceptive stimuli in rats under ketamine anesthesia.

  2008cites this paper
• Pharmacological fMRI - Challenges in Analysing Drug-Induced Single-Event BOLD Responses

  2007cites this paper
• Study-level wavelet cluster analysis and data-driven signal models in pharmacological MRI.

  2007cites this paper
• Pharmacological modulation of functional connectivity: the correlation structure underlying the phMRI response to d-amphetamine modified by selective dopamine D3 receptor antagonist SB277011A.

  2007cites this paper
• Mapping the central effects of ketamine in the rat using pharmacological MRI

  2006cites this paper
• Differential effects of cocaine and ketamine on time estimation: implications for neurobiological models of interval timing.

  2006cites this paper
• Using the BOLD MR signal to differentiate the stereoisomers of ketamine in the rat

  2006cites this paper
• ELECTIVE POTENTIATION OF THE METABOTROPIC GLUTAMATE ECEPTOR SUBTYPE 2 BLOCKS PHENCYCLIDINE-INDUCED YPERLOCOMOTION AND BRAIN ACTIVATION

  year unknowncites this paper